Biblio Discovery — Demo Discovery Service

5 results for "Shigeru Fujimura"

Showing 1–5 · 0.14 seconds · RSS

  1. Journal Article Full text

    Lactococcus lactis Strain Plasma Uniquely Induces IFN-α Production via Plasmacytoid Dendritic Cell Activation: A Comparative Study of Postbiotic Products

    Shigeru Fujimura; Masato Kawamura; Yurina Tamura

    Microorganisms, Vol. 13 No. 10 · 2025 · English · DOAJ Scopus

    Postbiotics are increasingly incorporated into functional foods and supplements due to their potential health benefits, particularly immune modulation. However, the mechanisms by which these products influence antiviral immunity remain incompletely understood. Type I interferons, especially…

  2. Journal Article

    Sterilization in liquids by air plasma under intermittent discharge

    Kairi MURAMATSU; Takehiko SATO; Tomoki NAKAJIMA et al.

    Mechanical Engineering Journal, Vol. 7 No. 1 · 2020 · English · DOAJ

    In recent years, cold atmospheric plasma has received attention for medical applications like sterilization, injure treatment, and cancer cell treatment. Plasma sterilization is effective against a wide range of microorganisms. Plasma sterilization devices for contact lens have developed over the…

  3. Journal Article Full text

    Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics

    Ping Yang; Shigeru Fujimura; Yawei Du et al.

    Antibiotics, Vol. 10 No. 9 · 2021 · English · DOAJ Scopus

    This study aimed to provide comparative information of pharmaceutical properties, including particle morphology and distribution uniformity, solubility, presence of residual solvent and insoluble particles, and antimicrobial activities, between brand-name meropenem (Mepem®, BNM) and its six generic…

  4. Journal Article

    Overproduction of Chromosomal ampC β-Lactamase Gene Maintains Resistance to Cefazolin in Escherichia coli Isolates

    Masato Kawamura; Ryota Ito; Yurina Tamura et al.

    Microbiology Spectrum, Vol. 10 No. 3 · 2022 · English · DOAJ Scopus

    ABSTRACT Cefazolin, an active in vitro agent against Escherichia coli, is used to treat urinary and biliary tract infections. Cefazolin is used widely as an antibiotic, and the increase in the emergence of cefazolin-resistant E. coli in many countries is a major concern. We investigated the changes…